nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.0545	0.0545	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CXCR2—periodontitis	0.0473	0.0473	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL13—periodontitis	0.0397	0.0397	CbGpPWpGaD
Eprosartan—AGTR1—Arf6 signaling events—MET—periodontitis	0.0376	0.0376	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CCR2—periodontitis	0.0368	0.0368	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL17A—periodontitis	0.0366	0.0366	CbGpPWpGaD
Eprosartan—AGTR1—ACE Inhibitor Pathway—TGFB1—periodontitis	0.0346	0.0346	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL3—periodontitis	0.0345	0.0345	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.0313	0.0313	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.0264	0.0264	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1A—periodontitis	0.025	0.025	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL10—periodontitis	0.0249	0.0249	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL4—periodontitis	0.0242	0.0242	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—periodontitis	0.0236	0.0236	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.0231	0.0231	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FGF2—periodontitis	0.0224	0.0224	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCR2—periodontitis	0.0222	0.0222	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL3—periodontitis	0.0176	0.0176	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.0174	0.0174	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR2—periodontitis	0.0173	0.0173	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.0149	0.0149	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IFNG—periodontitis	0.0146	0.0146	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.0138	0.0138	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—periodontitis	0.0136	0.0136	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CXCL8—periodontitis	0.0136	0.0136	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.0135	0.0135	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.0135	0.0135	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1B—periodontitis	0.013	0.013	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—GGT1—periodontitis	0.0119	0.0119	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.0119	0.0119	CbGpPWpGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.0116	0.0116	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.0116	0.0116	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.0115	0.0115	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—GGT1—periodontitis	0.0115	0.0115	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCR2—periodontitis	0.0114	0.0114	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TGFB1—periodontitis	0.0101	0.0101	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL3—periodontitis	0.00996	0.00996	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TNF—periodontitis	0.00946	0.00946	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—AGER—periodontitis	0.00916	0.00916	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL3—periodontitis	0.00905	0.00905	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR2—periodontitis	0.00883	0.00883	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—ADRB1—periodontitis	0.00879	0.00879	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL2—periodontitis	0.00852	0.00852	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—VIP—periodontitis	0.0072	0.0072	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—periodontitis	0.00674	0.00674	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—VIP—periodontitis	0.00654	0.00654	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCR2—periodontitis	0.00642	0.00642	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCR2—periodontitis	0.00583	0.00583	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00572	0.00572	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—periodontitis	0.00554	0.00554	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL3—periodontitis	0.00534	0.00534	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR2—periodontitis	0.00499	0.00499	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADRB1—periodontitis	0.00497	0.00497	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR2—periodontitis	0.00453	0.00453	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00452	0.00452	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADRB1—periodontitis	0.00451	0.00451	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GGT1—periodontitis	0.00443	0.00443	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL2—periodontitis	0.00435	0.00435	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFB1—periodontitis	0.00387	0.00387	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VIP—periodontitis	0.00386	0.00386	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCR2—periodontitis	0.00344	0.00344	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL8—periodontitis	0.00344	0.00344	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MMP3—periodontitis	0.00344	0.00344	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00343	0.00343	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR2—periodontitis	0.00268	0.00268	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRB1—periodontitis	0.00267	0.00267	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—PPARA—periodontitis	0.00264	0.00264	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC52A3—periodontitis	0.00231	0.00231	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—periodontitis	0.00223	0.00223	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTRK1—periodontitis	0.00218	0.00218	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP3—periodontitis	0.00203	0.00203	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL8—periodontitis	0.00194	0.00194	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL8—periodontitis	0.00177	0.00177	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.0017	0.0017	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACP5—periodontitis	0.00136	0.00136	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—periodontitis	0.00132	0.00132	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.00122	0.00122	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGF2—periodontitis	0.00119	0.00119	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL8—periodontitis	0.00104	0.00104	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—periodontitis	0.000992	0.000992	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—periodontitis	0.000944	0.000944	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000792	0.000792	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—periodontitis	0.000778	0.000778	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GGT1—periodontitis	0.000758	0.000758	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—periodontitis	0.000586	0.000586	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARA—periodontitis	0.000542	0.000542	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—periodontitis	0.000353	0.000353	CbGpPWpGaD
